Inventor · disambiguated record
Pascal Grenier
Also filed as: BICHON DANIEL · GRENIER PASCAL · SCHNEIDER MICHEL
34 granted patents·28 pending applications·1,002 citations·filing 1992–2021
98Inventor score
Top patents by PatentIndex Score
62 records- 0197US5413774ALong-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereofBRACCO INT BV·Filed 1992·Granted May 9, 1995·253 cites·14 claims
- 0294US6027748APharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorptionJAGOTEC AG·Filed 1998·Granted Feb 22, 2000·194 cites·15 claims
- 0394US5578292ALong-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereofBRACCO INT BV·Filed 1995·Granted Nov 26, 1996·127 cites·20 claims
- 0492US6149940ATablet with controlled release of alfuzosine chlorhydrateSYNTHELABO·Filed 1997·Granted Nov 21, 2000·150 cites·23 claims
- 0591US8394407B2Delayed release tablet with defined core geometryVERGNAULT GUY·Filed 2012·Granted Mar 12, 2013·14 cites·19 claims
- 0689US8927028B2Pharmaceutical composition containing coated, floating particlesGRENIER PASCAL·Filed 2005·Granted Jan 6, 2015·27 cites·13 claims
- 0788US6485705B1Mixable combination for generating a suspension of stable microbubbles for ultrasonic imagingBRACCO INT BV·Filed 2000·Granted Nov 26, 2002·12 cites·17 claims
- 0887US8460706B2Hydrophilic/lipophilic polymeric matrix dosage formulationVERGNAULT GUY·Filed 2011·Granted Jun 11, 2013·8 cites·25 claims
- 0985US9622980B2Controlled release compositionsJAGOTEC AG·Filed 2015·Granted Apr 18, 2017·5 cites·23 claims
- 1085US7927624B2Hydrophilic/lipophilic polymeric matrix dosage formulationJAGOTEC AG·Filed 2007·Granted Apr 19, 2011·5 cites·35 claims
- 1185US6896875B2Mixable combination for generating a suspension of stable microbubbles for ultrasonic imagingBRACCO INT BV·Filed 2002·Granted May 24, 2005·8 cites·2 claims
- 1285US6221395B1Controlled release pharmaceutical tablets containing an active principle of low water solubilityJAGOTEC AG·Filed 1998·Granted Apr 24, 2001·76 cites·4 claims
- 1385US6136293AStable microbubbles suspensions containing saturated lamellar phospholipidsBRACCO INT BV·Filed 1998·Granted Oct 24, 2000·38 cites·24 claims
- 1484US8168218B2Delayed release tablet with defined core geometryVERGNAULT GUY·Filed 2004·Granted May 1, 2012·16 cites·9 claims
- 1583US8309124B2Delayed release tablet with defined core geometryVERGNAULT GUY·Filed 2012·Granted Nov 13, 2012·5 cites·14 claims
- 1681US6881397B2Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereofBRACCO INT BV·Filed 2002·Granted Apr 19, 2005·7 cites·26 claims
- 1779US8303986B2Hydrophilic/lipophilic polymeric matrix dosage formulationVERGNAULT GUY·Filed 2009·Granted Nov 6, 2012·2 cites·7 claims
- 1878US7083778B2Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2003·Granted Aug 1, 2006·6 cites·5 claims
- 1977US10076500B2Floating gastric retentive dosage formJAGOTEC AG·Filed 2016·Granted Sep 18, 2018·1 cites·26 claims
- 2077US6592846B1Long-lasting aqueous dispersions or suspensions of pressure resistant gas-filled microvesicles and methods for thereof preparation thereofBRACCO INT BV·Filed 2000·Granted Jul 15, 2003·5 cites·7 claims
- 2176US9314430B2Floating gastric retentive dosage formGRENIER PASCAL·Filed 2011·Granted Apr 19, 2016·1 cites·15 claims
- 2275US9101544B2Controlled release nisoldipine compositionsGRENIER PASCAL·Filed 2007·Granted Aug 11, 2015·2 cites·24 claims
- 2374US8003690B2Topical nanoparticulate spironolactone formulationJAGOTEC AG·Filed 2002·Granted Aug 23, 2011·9 cites·20 claims
- 2473US9040085B2Delayed release tablet with defined core geometryJAGOTEC AG·Filed 2014·Granted May 26, 2015·1 cites·11 claims
- 2573US7838028B2Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of sameJAGOTEC AG·Filed 2002·Granted Nov 23, 2010·8 cites·12 claims
- 2672US9186332B2Delayed release tablet with defined core geometryJAGOTEC AG·Filed 2012·Granted Nov 17, 2015·1 cites·18 claims
- 2767US2005207980A1Stable microbubbles suspensions injectable into living organismsBRACCO INT BV·Filed 2005·Application pending·0 cites
- 2866US2005058605A1Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereofFiled 2004·Application pending·0 cites
- 2962US2006257321A1Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2006·Application pending·0 cites
- 3060US2008221174A1Controlled release nisoldipine compositionsJAGOTEC AG·Filed 2008·Application pending·0 cites
- 3158US9884021B2Delayed release tablet with defined core geometryJAGOTEC AG·Filed 2015·Granted Feb 6, 2018·0 cites·15 claims
- 3258US6989141B2Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2002·Granted Jan 24, 2006·0 cites·1 claims
- 3358US2006034771A1Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2005·Application pending·0 cites
- 3457US2023277448A1Chewable formulationsELANCO TIERGESUNDHEIT AG·Filed 2021·Application pending·0 cites
- 3555US2004208826A1Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2004·Application pending·0 cites
- 3654US2008069886A1Spironolactone nanoparticles, compositions and methods related theretoJAGOTEC AG·Filed 2007·Application pending·0 cites
- 3754US2007148229A1Tablet with coloured coreJAGOTEC AG·Filed 2004·Application pending·0 cites
- 3852US6613306B1Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 1999·Granted Sep 2, 2003·16 cites·5 claims
- 3951US2003185759A1Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2003·Application pending·0 cites
- 4051US2003194376A1Ultrasound contrast agents and methods of making and using themBRACCO INT BV·Filed 2003·Application pending·0 cites
- 4150US2003180359A1Hydrophilic/ lipophilic polymeric matrix dosage formulationFiled 2001·Application pending·0 cites
- 4249US2003064030A1Ultrasound contrast agents and methods of making and using themFiled 2002·Application pending·0 cites
- 4349US2014243296A1Organic CompoundsJAGOTEC AG·Filed 2012·Application pending·0 cites
- 4449US2010291209A1Organic compoundsVERGNAULT GUY·Filed 2008·Application pending·0 cites
- 4548US2010196475A1Controlled release tablet formulation containing magnesium aluminometasilicateGRENIER PASCAL·Filed 2008·Application pending·0 cites
- 4648US2010092557A1Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid AnalgesicVERGNAULT GUY·Filed 2007·Application pending·0 cites
- 4747US8927608B2Compositions comprising amphetamin and lisdexamfetamineVERGNAULT GUY·Filed 2011·Granted Jan 6, 2015·0 cites·21 claims
- 4847US8663693B2Nanoparticulate formulations of fenofibrateGRENIER PASCAL·Filed 2002·Granted Mar 4, 2014·0 cites·8 claims
- 4947US2014255499A1Method of Forming Fine Particles of a Drug SubstanceJAGOTEC AG·Filed 2012·Application pending·0 cites
- 5047US2010233259A1Dosage form of ropiniroleGRENIER PASCAL·Filed 2009·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pascal Grenier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →